$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!
Idera Pharmaceuticals, Inc.(NASDAQ : IDRA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Loading IDRA News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.39%||79.77||1.3%||$810.55m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.68%||402.97||3.4%||$311.23m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.36%||129.63||2.7%||$186.81m|
|BMRN||BioMarin Pharmaceutical Inc.||1.32%||96.22||4.2%||$183.84m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.74%||97.09||2.2%||$112.19m|
|IONS||Ionis Pharmaceuticals, Inc.||1.75%||30.90||11.4%||$96.76m|
|A||Agilent Technologies, Inc.||0.13%||47.32||0.9%||$93.68m|
|EXAS||Exact Sciences Corporation||0.74%||19.19||22.9%||$86.20m|
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera's immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while its third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.